200 related articles for article (PubMed ID: 29115540)
1. MicroRNA-326 inhibits melanoma progression by targeting KRAS and suppressing the AKT and ERK signalling pathways.
Kang K; Zhang J; Zhang X; Chen Z
Oncol Rep; 2018 Jan; 39(1):401-410. PubMed ID: 29115540
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA‑337 inhibits colorectal cancer progression by directly targeting KRAS and suppressing the AKT and ERK pathways.
Liu X; Wang Y; Zhao J
Oncol Rep; 2017 Nov; 38(5):3187-3196. PubMed ID: 29048669
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA SNHG14 accelerates cell proliferation, migration, invasion and suppresses apoptosis in colorectal cancer cells by targeting miR-944/KRAS axis through PI3K/AKT pathway.
Pei Q; Liu GS; Li HP; Zhang Y; Xu XC; Gao H; Zhang W; Li T
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9871-9881. PubMed ID: 31799655
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-433 inhibits cervical cancer progression by directly targeting metadherin to regulate the AKT and β-catenin signalling pathways.
Liang C; Ding J; Yang Y; Deng L; Li X
Oncol Rep; 2017 Dec; 38(6):3639-3649. PubMed ID: 29130111
[TBL] [Abstract][Full Text] [Related]
5. miR-216b Post-Transcriptionally Downregulates Oncogene KRAS and Inhibits Cell Proliferation and Invasion in Clear Cell Renal Cell Carcinoma.
Wang Y; Dong D; Jiang S; Zhang E; Zheng W; Mao L; Li W; Zhou J; Fan L; Cheng R; Li Z; Fang Z; Gui Y; Li X
Cell Physiol Biochem; 2018; 49(5):1755-1765. PubMed ID: 30231239
[TBL] [Abstract][Full Text] [Related]
6. MiR-126 Regulates the ERK Pathway via Targeting KRAS to Inhibit the Glioma Cell Proliferation and Invasion.
Li Y; Li Y; Ge P; Ma C
Mol Neurobiol; 2017 Jan; 54(1):137-145. PubMed ID: 26732596
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.
Li WF; Dai H; Ou Q; Zuo GQ; Liu CA
Tumour Biol; 2016 May; 37(5):5885-95. PubMed ID: 26589417
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA‑539 inhibits the proliferation and invasion of bladder cancer cells by regulating IGF‑1R.
Liao G; Chen F; Zhong J; Jiang X
Mol Med Rep; 2018 Apr; 17(4):4917-4924. PubMed ID: 29393438
[TBL] [Abstract][Full Text] [Related]
9. miR-216b suppresses tumor growth and invasion by targeting KRAS in nasopharyngeal carcinoma.
Deng M; Tang H; Zhou Y; Zhou M; Xiong W; Zheng Y; Ye Q; Zeng X; Liao Q; Guo X; Li X; Ma J; Li G
J Cell Sci; 2011 Sep; 124(Pt 17):2997-3005. PubMed ID: 21878506
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-34b/c suppresses uveal melanoma cell proliferation and migration through multiple targets.
Dong F; Lou D
Mol Vis; 2012; 18():537-46. PubMed ID: 22419847
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-613 inhibited ovarian cancer cell proliferation and invasion by regulating KRAS.
Fu X; Cui Y; Yang S; Xu Y; Zhang Z
Tumour Biol; 2016 May; 37(5):6477-83. PubMed ID: 26631045
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-134 modulates glioma cell U251 proliferation and invasion by targeting KRAS and suppressing the ERK pathway.
Zhao Y; Pang D; Wang C; Zhong S; Wang S
Tumour Biol; 2016 Aug; 37(8):11485-93. PubMed ID: 27012554
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-485-5p represses melanoma cell invasion and proliferation by suppressing Frizzled7.
Wu J; Li J; Ren J; Zhang D
Biomed Pharmacother; 2017 Jun; 90():303-310. PubMed ID: 28364602
[TBL] [Abstract][Full Text] [Related]
14. MiR-637 suppresses melanoma progression through directly targeting P-REX2a and inhibiting PTEN/AKT signaling pathway.
Zhang J; Liu WL; Zhang L; Ge R; He F; Gao TY; Tian Q; Mu X; Chen LH; Chen W; Li X
Cell Mol Biol (Noisy-le-grand); 2018 Aug; 64(11):50-57. PubMed ID: 30213289
[TBL] [Abstract][Full Text] [Related]
15. microRNA-27a functions as a tumor suppressor in esophageal squamous cell carcinoma by targeting KRAS.
Zhu L; Wang Z; Fan Q; Wang R; Sun Y
Oncol Rep; 2014 Jan; 31(1):280-6. PubMed ID: 24154848
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-197 inhibits gastric cancer progression by directly targeting metadherin.
Liao Z; Li Y; Zhou Y; Huang Q; Dong J
Mol Med Rep; 2018 Jan; 17(1):602-611. PubMed ID: 29115517
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive profiling of novel microRNA-9 targets and a tumor suppressor role of microRNA-9 via targeting IGF2BP1 in hepatocellular carcinoma.
Zhang J; Cheng J; Zeng Z; Wang Y; Li X; Xie Q; Jia J; Yan Y; Guo Z; Gao J; Yao M; Chen X; Lu F
Oncotarget; 2015 Dec; 6(39):42040-52. PubMed ID: 26547929
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-411 inhibits malignant biological behaviours of colorectal cancer cells by directly targeting PIK3R3.
Zhao J; Xu J; Zhang R
Oncol Rep; 2018 Feb; 39(2):633-642. PubMed ID: 29207180
[TBL] [Abstract][Full Text] [Related]
19. MiR-193a-3p is an Important Tumour Suppressor in Lung Cancer and Directly Targets KRAS.
Fan Q; Hu X; Zhang H; Wang S; Zhang H; You C; Zhang CY; Liang H; Chen X; Ba Y
Cell Physiol Biochem; 2017; 44(4):1311-1324. PubMed ID: 29183007
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-486 inhibits cell proliferation, invasion and migration via down-regulating the TENM1 expressions and affecting ERK and Akt signaling pathways and epithelial-to-mesenchymal transition in papillary thyroid carcinoma.
Sun YH; Liu ZF; Yang BB; Yu B
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8429-8439. PubMed ID: 31646573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
